Experimental infarct size reduction with calcium channel blockers
- 30 September 1991
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 18 (3) , 876-878
- https://doi.org/10.1016/0735-1097(91)90815-q
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heartJournal of the American College of Cardiology, 1991
- Myocardial stunning and hibernation. The physiology behind the colloquialisms.Circulation, 1991
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardiumJournal of the American College of Cardiology, 1989
- Effect of verapamil on postischemic “stunned” myocardium: Importance of the timing of treatmentJournal of the American College of Cardiology, 1988
- An Overview of the Clinical Trials of Agents (Other than β-Blockers) That Potentially Limit Myocardial Infarct SizeJournal of Cardiovascular Pharmacology, 1988
- Effects of calcium antagonists on infarcting myocardiumThe American Journal of Cardiology, 1987
- Diltiazem and Reinfarction in Patients with Non-Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1986
- Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: Critical importance of the timing of treatmentThe American Journal of Cardiology, 1985
- Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.Circulation Research, 1985